Menu
Recruiting NCT07158463

Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit of Sohag University Hospital

Observational Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Experience With Therapeutic Plasma Exchange in the Pediatric Nephrology Unit. Basic parameters: 1 year — 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Plasmapheresis also known as a therapeutic plasma exchange (TPE) TPE is an extracorporeal blood purification technique designed for the removal of large-molecular-weight substances. Examples of these substances include pathogenic autoantibodies, immune complexes, cryoglobulins, myeloma light chains, endotoxin, and cholesterol-containing lipoproteins Document the indications, procedures, outcomes, and complications associated with TPE in pediatric patients at Sohag University Hospital. To compare our findings with existing national and international data to identify areas for improvement and standardization. To evaluate the safety and efficacy of TPE in our pediatric nephrology unit.

Primary outcome measures

  • Efficacy of therapeutic plasma exchange in pediatric nephrology unit [Time frame: One month after last session]

Eligibility criteria

Inclusion criteria

All pediatric patients (aged 1-18 years) who underwent TPE during the study period.

Both male and female.

Exclusion criteria

Patients who cannot tolerate central line placement Patients who are in an actively septic state or are hemodynamically unstable . Patients who have allergies to fresh frozen plasma (FFP) or albumin, depending on the type of plasma exchange

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Egypt · 1 center
  • Faculty of medicine sohag university — Sohag

Identifiers

NCT: NCT07158463 · Soh-Med--25-8-7MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗